
M2M Pulse: 7 Trends CDMO You Can’t Ignore
From Molecule to Market: Inside the outsourcing space by Raman Sehgal
March 6, 2026 · 26 min · Episode 262
About this episode
This episode explores overlooked trends in the CDMO ecosystem for 2026 with insights from industry leaders.
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO and C-suite leaders from the CDMO ecosystem, exploring the overlooked trends for 2026. Nick Fortin, CEO, Codis Ankit Gupta, CEO, InstaPill Eric Edwards, MD, PhD, CEO, Phlow USA Dirk T. Lange, CEO, Pyramid Pharma Services Kaan-Fabian Kekec, Partner, Simon-Kucher Healthcare and Life Sciences J.D. Mowery, President, CDMO Division, Bora Pharmaceuticals Matthew Bio, CSO, Cambrex and President, Snapdragon Chemistry Bill Vincent, Biotech Entrepreneur, CEO and Board Member Philip Macnabb, CEO, Curia Christiane Bardroff, COO Leader Jason Anderson, CEO, Ensera Mark B, Anonymous CEO (not to be quoted by name) Adam Siebert, Managing Director, L.E.K. Consulting Stephen Dilly, CEO, Sonoma Biotherapeutics Elisabeth Stampa, CEO, Medichem Jon Alberdi, CEO, Vivebiotech Derek Hennecke, Founder, Investor and Board Member Bruce Thompson, CTO, Kincell Bio Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global…
People in this episode
Host: Raman Sehgal
Guests: Nick Fortin, Ankit Gupta, Eric Edwards, Dirk T. Lange, Kaan-Fabian Kekec, J.D. Mowery, Matthew Bio, Bill Vincent, Adam Siebert, Stephen Dilly, Elisabeth Stampa, Jon Alberdi, Derek Hennecke, Bruce Thompson
Topics covered
- CDMO
- drug development
- outsourcing
- trends
- life sciences
- CEO insights
Keywords
- CDMO
- drug development
- outsourcing
- trends
- life sciences
- CEO
- pharmaceuticals
- biotech
Sponsors
Bora Pharmaceuticals
Mentioned in this episode
Organizations: Kincell Bio, Codis, InstaPill, Phlow USA, Pyramid Pharma Services, Simon-Kucher Healthcare and Life Sciences, Bora Pharmaceuticals, Cambrex, Anonymous CEO, L.E.K. Consulting
More episodes of Molecule to Market: Inside the outsourcing space
- From Lab to Boardroom at Sartorius · June 12, 2026 · 50 min
- CDMO Live Europe: State of Contract Manufacturing 2026 · May 29, 2026 · 35 min
- Codexis at TIDES - Stereochemistry in RNA Manufacturing: Signal or Noise? · May 22, 2026 · 51 min
- Navigating global supply chains at Big Pharma · May 15, 2026 · 60 min
- Bora Live Panel - The Voice of the Customer · May 8, 2026 · 56 min
- The Making of a CGT CDMO Builder · May 1, 2026 · 58 min
Explore listener stats, chart rankings, contacts and more on the Molecule to Market: Inside the outsourcing space podcast page.